Considering that a tumor suppressor gene can acquire mutations with oncogenic roles outside of the miRNA binding sites (e.g., TP53), the tumor suppressor value of a miRNA can switch to oncogenic and vice versa in respect to the genetic integrity of the target genes. This evidence concerns the gene TP53 and neoplasm.